OUR publications

The DM-Scope concept:

“The DM-Scope registry: a rare disease innovative framework bridging the gap between research and medical care”

De Antonio M, Dogan C, Daidj F, Eymard B, Puymirat J, Mathieu J, Gagnon C, Katsahian S, Filnemus Myotonic Dystrophy Study Group, Hamroun D, Bassez G.

Orphanet Journal of Rare Diseases. 2019 June.

Description of the pediatric population:

“A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management. “

Lagrue E, Dogan C, De Antonio M, Pediatric Filnemus Myotonic Dystrophy Study Group, Hamroun D, Bassez G.

Neurology. 2019 Feb.


Classification in 5 forms:

“Unraveling the myotonic dystrophy type 1 clinical spectrum: a systematic registry-based study – Implications for disease classification.”

De Antonio M*, Dogan C*, Hamroun D, Fabbro M, Chevalier P, Mati M, DM-Scope network, Eymard B, Katsahian S and Bassez G.

Revue Neurologique. 2016 Sept.


A gender risk factor:

“Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study.”

Dogan C*, De Antonio M*, Hamroun D, Varet H, Fabbro M, Rougier F, French Myotonic Dystrophy Clinical Network, Gherardi RK, Eymard B, Puymirat J, Katsahian S, Bassez G.

PLoS One. 2016 Feb.

Close Menu